Based on the study by Teng et al., the TGF-β pathway-related lncRNAs EPB41L4A-AS2, LINC00515, and miR4435-2HG are dysregulated in the head and neck carcinoma, with EPB41L4A-AS2 serving to repress TGFBR1 and limit TGF-β's ability to drive the EMT progression. The gene discussed is TGFB1; the disease is head and neck carcinoma.